305 studies found for:    Open Studies | "Triplets"
Show Display Options
Rank Status Study
21 Recruiting Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
Condition: Locally Recurrent/Metastatic Triple Negative Breast Cancer
Interventions: Radiation: external beam radiation therapy;   Drug: cisplatin;   Procedure: Biopsy of Target Tumor
22 Recruiting A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple Negative Breast Cancer (IMpassion130)
Condition: Metastatic Breast Cancer, Triple Negative Breast Cancer
Interventions: Drug: Atezolizumab [TECENTRIQ];   Drug: Nab-Paclitaxel;   Drug: Placebo
23 Not yet recruiting Safety and Efficacy Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Condition: Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer
Intervention: Drug: OTS167PO
24 Recruiting Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy
Conditions: Triple Negative Breast Cancer;   Triple-Negative Breast Cancer;   Triple Negative Breast Neoplasms
Intervention: Biological: Personalized polyepitope DNA vaccine
25 Recruiting Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
Conditions: Triple Negative Breast Cancer;   Triple Negative Breast Neoplasms;   Triple-Negative Breast Cancer
Interventions: Biological: Personalized synthetic long peptide vaccine (Poly ICLC);   Drug: Poly ICLC
26 Recruiting NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Cancer
Intervention: Drug: Everolimus
27 Recruiting Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
Conditions: Breast Cancer;   Metastatic Triple Negative
Interventions: Drug: Pembrolizumab;   Radiation: Radiotherapy
28 Recruiting Romidepsin Plus Cisplatin in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Conditions: Triple-Negative Breast Cancer;   Breast Cancer
Interventions: Drug: Romidepsin;   Drug: Cisplatin
29 Not yet recruiting A Phase I/II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Docetaxel Monotherapy in Patients With Advanced/Metastatic Triple Negative Breast Cancer (TNBC).
Condition: Triple Negative Breast Cancer
Intervention: Drug: BLEX 404 Oral Liquid
30 Recruiting Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
Conditions: Breast Cancer;   Capecitabine;   Triple Negative Breast Cancer
Intervention:
31 Recruiting Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Conditions: Breast Neoplasms;   Triple Negative Breast Neoplasms
Interventions: Drug: Dasatinib;   Procedure: Conventional Surgery;   Other: Laboratory Biomarker Analysis
32 Recruiting Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
Conditions: Advanced Melanoma;   Triple-Negative Breast Cancer
Interventions: Biological: Imprime PGG;   Drug: Pembrolizumab
33 Recruiting Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients
Conditions: Triple-Negative Invasive Breast Carcinoma;   Residual Tumor
Interventions: Drug: Carmustine;   Drug: Cyclophosphamide;   Drug: Carboplatin;   Procedure: Autologous Hematopoietic Stem Cell Transplantation
34 Recruiting Huaier Granule in Treating Women With Triple Negative Breast Cancer
Condition: Triple Negative Breast Cancer
Intervention: Drug: Huaier Granule
35 Recruiting Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Condition: Triple Negative Breast Cancer
Interventions: Drug: Everolimus;   Drug: Eribulin
36 Recruiting Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
Conditions: Triple-Negative Breast Neoplasms;   Breast Neoplasm;   Breast Cancer;   Triple-Negative Breast Cancer
Interventions: Drug: Trilaciclib;   Drug: Gemcitabine;   Drug: Carboplatin
37 Recruiting Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC
Condition: Triple Negative Breast Cancer
Intervention: Drug: ENMD-2076
38 Recruiting Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
Condition: Triple Negative Breast Cancer
Interventions: Drug: Pembrolizumab;   Drug: Paclitaxel;   Drug: Capecitabine
39 Recruiting Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib
Condition: Triple Negative Breast Cancer
Intervention: Drug: Afatinib
40 Recruiting Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Conditions: Breast Cancer;   Early Stage;   Triple Negative Breast Cancer
Interventions: Drug: Enzalutamide;   Behavioral: assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.